Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | AMGN | GILD | CELG | VRTX |
| Company | Adverum Biotechnologies Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.20 | 273.45 | 67.47 | 108.01 | 402.44 |
| High | 10.22 | 274.35 | 67.90 | 108.59 | 403.88 |
| Low | 9.34 | 267.24 | 65.09 | 107.27 | 393.00 |
| Last | 9.39 | 269.38 | 65.27 | 108.24 | 397.70 |
| Change | -0.80 | -3.63 | -1.81 | +0.11 | -3.06 |
| % Change | -7.85% | -1.33% | -2.70% | +0.10% | -0.76% |
| Volume | 847,500 | 1,794,000 | 15,171,900 | 191,230,496 | 787,600 |
| 20-Day Average Volume | 234,250 | 2,149,590 | 6,861,755 | 16,188,930 | 964,110 |
| Previous Close | 10.19 | 273.01 | 67.08 | 108.13 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.99 | 270.70 | 68.68 | 108.17 | 402.31 |
| 20-Day Raw Stochastic | 0.91% | 31.20% | 2.05% | 63.25% | 21.98% |
| 20-Day Relative Strength | 29.45% | 44.80% | 28.32% | 64.69% | 42.69% |
| Weighted Alpha | -32.96 | +9.12 | -23.73 | +46.30 | +14.87 |
| Today's Opinion | 56% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 24% Buy | 24% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.78% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | -1.97% since 11/13/19 | +1.07% since 04/18/24 |
| Low | 9.34 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 107.27 on 11/20/19 | 391.25 on 04/19/24 |
| High | 11.87 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -37.19% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | +5.14% since 10/18/19 | -4.41% since 03/25/24 |
| Low | 9.34 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 15.16 on 03/27/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +4.92% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | +13.63% since 08/20/19 | -7.50% since 01/25/24 |
| Low | 9.00 on 01/26/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 29.70 on 02/08/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -5.15% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +14.14% since 05/20/19 | +9.55% since 10/25/23 |
| Low | 7.40 on 12/29/23 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 29.70 on 02/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 211,493 | 146,436,016 | 83,519,768 | 77,035,920 | 103,580,040 |
| Shares Outstanding, K | 20,755 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 3,600,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -117,170,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -23,710,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.84 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.30 on 03/18/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 30.13 |